EUVIMEDOpdag EUVIMED
Crossref

Impact of Sampling Window Variability on Pharmacokinetic Parameters Estimated by Non‐Compartmental Analysis: Case Studies of Various Types of Drugs

Kyosuke Takahashi, Kazuhiko Asari, Kazuhiko Hanada

Clinical Pharmacology in Drug Development · 2026

DOI: 10.1002/cpdd.70004 ↗

At a glance

Journal article in Clinical Pharmacology in Drug Development, 2026. Written by Kyosuke Takahashi and 2 co-authors. Institution: Department of Pharmacometrics and Pharmacokinetics, Meiji Pharmaceutical University, Tokyo, Japan. Major MEDLINE topics: Blood Specimen Collection, Models, Biological, Pharmacokinetics. 22 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Non‐compartmental analysis (NCA) is commonly used to estimate pharmacokinetic (PK) parameters in individual participants during Phase 1 studies. PK sampling schedules are important for accurately characterizing a drug's PK profile. However, collecting blood samples on time is often challenging, even in Phase 1 studies involving healthy participants, due to tightly scheduled study activities. To address these constraints, sampling windows—defined as permissible time intervals for blood sample collection—are often implemented. These windows provide operational flexibility at clinical study sites while maintaining a reasonable level of accuracy in parameter estimation. To date, no published literature has described the construction of sampling windows for NCA, and the general practice of constructing sampling windows remains unstandardized. In this study, we evaluated the impact of varying sampling window lengths on NCA‐derived PK parameters, leveraging bioequivalence criteria as an indicator to assess the effects and provide insights into the construction of sampling windows for NCA. As a result, we were able to quantitatively evaluate how changes in sampling window length affect NCA‐based PK parameters. Based on these findings, we provide recommendations for appropriate sampling windows.

Subjects

MeSH terms (MEDLINE)

Blood Specimen CollectionModels, BiologicalPharmacokineticsHumansTherapeutic EquivalencyClinical Trials, Phase I as TopicTime FactorsPharmaceutical Preparations

Author keywords

anakinralorlatinibnon‐compartmental analysisrelebactamsampling window

Substances

Pharmaceutical Preparations

Authors and institutions

  • Department of Pharmacometrics and Pharmacokinetics, Meiji Pharmaceutical University, Tokyo, Japan.

Cite

APA

Takahashi, K., Asari, K., & Hanada, K. (2026). Impact of Sampling Window Variability on Pharmacokinetic Parameters Estimated by Non‐Compartmental Analysis: Case Studies of Various Types of Drugs. Clinical Pharmacology in Drug Development. https://doi.org/10.1002/cpdd.70004

Vancouver

Takahashi K, Asari K, Hanada K. Impact of Sampling Window Variability on Pharmacokinetic Parameters Estimated by Non‐Compartmental Analysis: Case Studies of Various Types of Drugs. Clinical Pharmacology in Drug Development. 2026. doi:10.1002/cpdd.70004

BibTeX
@article{Takahashi2026,
  author = {Takahashi, Kyosuke and Asari, Kazuhiko and Hanada, Kazuhiko},
  title = {Impact of Sampling Window Variability on Pharmacokinetic Parameters Estimated by Non‐Compartmental Analysis: Case Studies of Various Types of Drugs},
  journal = {Clinical Pharmacology in Drug Development},
  year = {2026},
  doi = {10.1002/cpdd.70004}
}
Start for free →